Dr. Dari Shalon
Dr. Dari Shalon has over 13 years of experience as an accomplished entrepreneur and investor focusing on life science-oriented ventures. At the age of 29, Dari became the cofounder, President, and CEO of Synteni, a company established to commercialize the DNA chip technology he developed at Stanford University. With his leadership, the company became a major player in the global genomics industry, resulting in the 1999 acquisition of Synteni by Incyte Genomics (NASDAQ: INCY).
After successfully integrating Synteni into Incyte, Dari became the Founder and Director of the Center for Genomics Research at Harvard University. The new multidisciplinary center integrated research from the departments of biology, chemistry, physics, engineering and computer science at Harvard to advance the understanding of complex biological systems.
Dari holds a PhD in Biotechnology Engineering from Stanford University and a BS and MS in Engineering and an MBA from MIT.